Sodium/Nucleoside Cotransporter 1 (SLC28A1) Antibody

REQUEST MORE INFO
Catalogue No: abx034665
Price: US$326.25
(Size: 80 µl)

Click on the image to see the image legend

Available Options

* Size:


Add to Shopping Cart Buy It Now GET A QUOTE

Documents

Datasheet SDS
Sodium-dependent and pyrimidine-selective. Exhibits the transport characteristics of the nucleoside transport system cit or N2 subtype (N2/cit) (selective for pyrimidine nucleosides and adenosine). It also transports the antiviral pyrimidine nucleoside analogs 3'-azido-3'-deoxythymidine (AZT) and 2', 3'-dideoxycytidine (ddC). It may be involved in the intestinal absorption and renal handling of pyrimidine nucleoside analogs used to treat acquired immunodeficiency syndrome (AIDS). It has the following selective inhibition: adenosine, thymidine, cytidine, uridine >> guanosine, inosine.

Target Sodium/Nucleoside Cotransporter 1 (SLC28A1)
Clonality Polyclonal
Reactivity Human
Tested Applications ELISA, WB
Host Rabbit
Recommended dilutions WB: 1/2000. Optimal dilutions/concentrations should be determined by the end user.
Conjugation Unconjugated
Immunogen KLH-conjugated synthetic peptide between 381-409 amino acids from the Central region of human SLC28A1.
Isotype IgG
Form Liquid
Purification Purified through a protein A column, followed by peptide affinity purification.
Storage Aliquot and store at -20°C. Avoid repeated freeze/thaw cycles.
UniProt Primary AC O00337 (UniProt, ExPASy)
UniProt Secondary AC A0AV42, A8K7I2, O00335, O00336, Q5U5S6, Q5U648, Q9UEZ9
UniProt Entry Name S28A1_HUMAN
Gene Symbol SLC28A1
GeneID 9154
HGNC 11001
KEGG hsa:9154
String 9606.ENSP00000378074
Molecular Weight Calculated MW: 71.6 kDa
Buffer PBS containing 0.09% sodium azide.
Specificity Predicted to react with Pig SLC28A1.
Availability Shipped within 5-10 working days.
Note THIS PRODUCT IS FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC, THERAPEUTIC OR COSMETIC PROCEDURES. NOT FOR HUMAN OR ANIMAL CONSUMPTION.
Research Articles on Sodium/Nucleoside Cotransporter 1 (SLC28A1)
Tags:
(Click to show)